Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-12-23
1998-09-08
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514370, A61K 31425
Patent
active
058045902
ABSTRACT:
Compounds of formula (I): ##STR1## where R.sup.1, R.sup.2, R.sup.4 and R.sup.5 are hydrogen or alkyl and R.sup.3 is hydrogen, alkyl or various organic groups are effective against osteoporosis at doses at which they also effectively control diabetes.
REFERENCES:
patent: 4572912 (1986-02-01), Yoshioka et al.
patent: 4687777 (1987-08-01), Meguro et al.
patent: 5317029 (1994-05-01), Inazu et al.
patent: 5338855 (1994-08-01), Yoshioka et al.
patent: 5407947 (1995-04-01), Bryant et al.
patent: 5436257 (1995-07-01), Fujita et al.
patent: 5476865 (1995-12-01), Panetta et al.
patent: 5576340 (1996-11-01), Fujita et al.
patent: 5578620 (1996-11-01), Fujita et al.
Lee et al., Diabetes, 43(12), 1435-9 (Abstract), 1994.
C. Jennermann et al, "Effects of Thiazolidinediones on Bone Turnover in the Rat", Journal of Bone and Mineral Research, vol. 10, Supplement 1, Aug. 1995.
Fujiwara Toshihiko
Horikoshi Hiroyoshi
Miyamoto Masaaki
Sankyo Company Limited
Schenkman Leonard
LandOfFree
Treatment and prophylaxis of osteoporosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment and prophylaxis of osteoporosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment and prophylaxis of osteoporosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1282408